中科院《国际期刊预警名单（试行）》名单
2023年01月发布的2023版：不在预警名单中
2021年12月发布的2021版：不在预警名单中
2021年01月发布的2020版：不在预警名单中
《国际期刊预警名单（试行）》2023版共计包含28本期刊（查看）
《国际期刊预警名单（试行）》2021版共计包含35本期刊（查看）
《国际期刊预警名单（试行）》2020版共计包含65本期刊（查看）
《Journal of Bone Oncology》相关链接
PubMed Central (PMC)链接：
http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2212-1374%5BISSN%5D
平均审稿速度：
20 Weeks
平均录用比例：
123学术网预审服务：
经过123学术网预审的论文，能够提前知晓自己的论文稿件是否达到自己目标分区、分值的杂志社的录用标准，同时节约自己大量投稿时间，若预审通过，123学术网客服会进一步向您反馈预审结果，如果双方对预审结果达成一致，则需要与我方签订咨询服务协议，以协助您结合审稿人的审稿意见进一步优化稿件质量，以实现文章录用结果。
若预审不能通过，说明论文稿件质量无法达到杂志社的录用标准，可考虑123学术网润色服务，不仅能满足Journal of Bone Oncology的语言要求，还能让Journal of Bone Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度被Journal of Bone Oncology编辑和审稿人充分理解和公正评估。
123学术网已助力全球10万+作者顺利发表论文。
《Journal of Bone Oncology》期刊简介
The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer.
As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject.
The areas covered by the journal include:
Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
Preclinical models of metastasis
Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
Bone imaging (clinical and animal, skeletal interventional radiology)
Bone biomarkers (clinical and translational applications)
Radiotherapy and radio-isotopes
Skeletal complications
Bone pain (mechanisms and management)
Orthopaedic cancer surgery
Primary bone tumours
Clinical guidelines
Multidisciplinary care
Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.
